MedTrace Logo

Virtual Reality Based Vision Test in Patients With AMD

NCT06241625 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-02-05

No results posted yet for this study

Summary

To assess the usability, tolerability, and repeatability of the set of VR headset-based tasks.

Conditions

  • Age-Related Macular Degeneration

Interventions

DIAGNOSTIC_TEST

Virtual Reality (VR) Contrast Function Test

Patients perform a new Virtual Reality (VR) Contrast Function Test

Sponsors & Collaborators

  • Apellis Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Augenklinik Zurich West

    lead OTHER

Principal Investigators

  • Stephan Michels, MD · Augenklinik Zurich West

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-20
Primary Completion
2024-02-29
Completion
2024-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06241625 on ClinicalTrials.gov